Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Structure-Based Drug Design for Epigenetic Targets Course

213 views

Published on

Join us on June 19 in Boston, MA, for this short course to be held prior to the start of CHI's Structure-Based Drug Design conference. This introductory course on drug design for epigenetic targets will focus especially on emerging targets such as bromodomain (readers), methyltransferase (writers) and lysine demethylase (erasers).

  • Be the first to comment

  • Be the first to like this

Structure-Based Drug Design for Epigenetic Targets Course

  1. 1. Structure-Based Drug Design for Epigenetic Targets ***** A Short Course Announcement ***** with Johnathan R. Whetstine, Ph.D., Assistant Professor of Medicine, Harvard Medical School & Philip Fallon, Ph.D., Senior Medicinal Chemist, Domainex Ltd. June 19, 2013 – The Revere Hotel – Boston, MAEpigenetic processes are the focus of intense interest, and the families of proteins that mediateepigenetic signalling are a highly promising source of new drug targets. Tackling this emergingfield of novel drug targets is not without its challenges. This workshop will review the contributionthat structural biology has made to the discovery of small molecule modulators. Structuralinformation can be invaluable in determining the druggability of potential targets, and in enablingmore efficient identification of hit molecules. Structural information can also guide the design ofcompounds with improved affinity for the target, or selectivity versus other targets. Thisintroductory course on drug design for epigenetic targets will focus especially on emerging targetssuch as bromodomain (readers), methyltransferase (writers) and lysine demethylase (erasers).This course will be held from 9:00 am – 12:00 pm prior to the start of CHI’s Structure-Based Drug Design conference (June 19-21).WAYS TO REGISTER:Online: https://chidb.com/register/2013/sbd/reg.aspCall: 781-972-5400Email: reg@healthtech.com http://www.healthtech.com/sbd

×